BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 18822700)

  • 1. Multiple bowel stenosis and perforation as long-term complications of chemoradiotherapy for advanced cervical cancer in a young woman: case report.
    Bifulco G; Mandato VD; Piccoli R; Bucci L; Giampaolino P; Nappi C
    Tumori; 2008; 94(4):592-5. PubMed ID: 18822700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemoradiation in cervical cancer with cisplatin and high-dose rate brachytherapy combined with external beam radiotherapy. Results of a phase-II study.
    Strauss HG; Kuhnt T; Laban C; Puschmann D; Pigorsch S; Dunst J; Koelbl H; Haensgen G
    Strahlenther Onkol; 2002 Jul; 178(7):378-85. PubMed ID: 12163992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extended-field radiotherapy and high-dose-rate brachytherapy with concurrent and adjuvant cisplatin-based chemotherapy for locally advanced cervical cancer: a phase I/II study.
    Chung YL; Jian JJ; Cheng SH; Hsieh CI; Tan TD; Chang HJ; Hung CF; Horng CF; Soong T; Tsou MH
    Gynecol Oncol; 2005 Apr; 97(1):126-35. PubMed ID: 15790448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicity of concurrent chemoradiotherapy for locally advanced cervical cancer.
    Jakubowicz J; Blecharz P; Skotnicki P; Reinfuss M; Walasek T; Luczynska E
    Eur J Gynaecol Oncol; 2014; 35(4):393-9. PubMed ID: 25118480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer.
    Rao GG; Rogers P; Drake RD; Nguyen P; Coleman RL
    Gynecol Oncol; 2005 Jan; 96(1):168-72. PubMed ID: 15589596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced radiosensitization with interferon-alpha-2b and cisplatin in the treatment of locally advanced cervical carcinoma.
    Stock RG; Dottino P; Jennings TS; Terk M; DeWyngaert JK; Beddoe AM; Cohen C
    Gynecol Oncol; 1997 Dec; 67(3):309-15. PubMed ID: 9441780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High complete response rate of concomitant chemoradiotherapy for locally advanced squamous cell carcinoma of the uterine cervix.
    Lin JC; Ho ES; Jan JS; Yang CH; Liu FS
    Gynecol Oncol; 1996 Apr; 61(1):101-8. PubMed ID: 8626094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer.
    Kokka F; Bryant A; Brockbank E; Powell M; Oram D
    Cochrane Database Syst Rev; 2015 Apr; (4):CD010260. PubMed ID: 25847525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent chemoradiotherapy or radiotherapy alone for locally advanced cervical cancer in elderly women.
    Park JH; Kim YS; Ahn SD; Choi EK; Shin SS; Kim YT; Kim YM; Kim JH; Yi SY; Nam JH
    Tumori; 2010; 96(6):959-65. PubMed ID: 21388059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pilot study on concurrent platinum chemotherapy and intracavitary brachytherapy for locally advanced cancer of the uterine cervix.
    Koumantakis E; Haralambakis Z; Koukourakis M; Mazonakis M; Haldeopoulos D; Papageorgiou N; Livas V; Froudarakis G; Varveris H
    Br J Radiol; 1998 May; 71(845):552-7. PubMed ID: 9691902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase II study of multimodality treatment for locally advanced cervical cancer: neoadjuvant carboplatin and paclitaxel followed by radical hysterectomy and adjuvant cisplatin chemoradiation.
    Dueñas-Gonzalez A; López-Graniel C; González-Enciso A; Cetina L; Rivera L; Mariscal I; Montalvo G; Gómez E; de la Garza J; Chanona G; Mohar A
    Ann Oncol; 2003 Aug; 14(8):1278-84. PubMed ID: 12881393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective randomized comparison of monthly fluorouracil and cisplatin versus weekly cisplatin concurrent with pelvic radiotherapy and high-dose rate brachytherapy for locally advanced cervical cancer.
    Kim YS; Shin SS; Nam JH; Kim YT; Kim YM; Kim JH; Choi EK
    Gynecol Oncol; 2008 Jan; 108(1):195-200. PubMed ID: 17963825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II study of concurrent chemoradiotherapy with high-dose-rate intracavitary brachytherapy in patients with locally advanced uterine cervical cancer: efficacy and toxicity of a low cumulative radiation dose schedule.
    Toita T; Kitagawa R; Hamano T; Umayahara K; Hirashima Y; Aoki Y; Oguchi M; Mikami M; Takizawa K;
    Gynecol Oncol; 2012 Aug; 126(2):211-6. PubMed ID: 22555110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of concurrent chemoradiotherapy plus adjuvant chemotherapy on advanced cervical cancer.
    Wang S; Zhang DS; Pan T; Liu S; Wang MK
    Chin J Cancer; 2010 Nov; 29(11):959-63. PubMed ID: 20979696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility and outcome of concurrent chemoradiotherapy for recurrent cervical carcinoma after initial surgery.
    Lee YS; Kim YS; Kim JH; Ahn SD; Lee SW; Shin SS; Nam JH; Kim YT; Kim YM; Kim JH; Choi EK
    Tumori; 2010; 96(4):553-9. PubMed ID: 20968134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II study of concurrent chemoradiotherapy with weekly cisplatin and paclitaxel in patients with locally advanced uterine cervical cancer: The JACCRO GY-01 trial.
    Umayahara K; Takekuma M; Hirashima Y; Noda SE; Ohno T; Miyagi E; Hirahara F; Hirata E; Kondo E; Tabata T; Nagai Y; Aoki Y; Wakatsuki M; Takeuchi M; Toita T; Takeshima N; Takizawa K
    Gynecol Oncol; 2016 Feb; 140(2):253-8. PubMed ID: 26701414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preoperative concurrent radiation therapy and chemotherapy for operable bulky carcinomas of uterine cervix stages IB2, IIA, and IIB with proximal parametrial invasion].
    Lerouge D; Touboul E; Lefranc JP; Uzan S; Jannet D; Moureau-Zabotto L; Genestie C; Antoine M; Jamali M
    Cancer Radiother; 2004 Jun; 8(3):168-77. PubMed ID: 15217584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Randomized Controlled Trial Comparing Clinical Outcomes and Toxicity of Lobaplatin- Versus Cisplatin-Based Concurrent Chemotherapy Plus Radiotherapy and High-Dose-Rate Brachytherapy for FIGO Stage II and III Cervical Cancer.
    Wang JQ; Wang T; Shi F; Yang YY; Su J; Chai YL; Liu Z
    Asian Pac J Cancer Prev; 2015; 16(14):5957-61. PubMed ID: 26320479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrent Chemo- Radiobrachytherapy with Cisplatin and Medium Dose Rate Intra- Cavitary Brachytherapy for Locally Advanced Uterine Cervical Cancer.
    Aghili M; Andalib B; Karimi Moghaddam Z; Maddah Safaie A; Amoozgar Hashemi F; Mousavi Darzikolaie N
    Asian Pac J Cancer Prev; 2018 Oct; 19(10):2745-2750. PubMed ID: 30360600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcomes of concomitant chemoradiotherapy incorporating high-dose-rate brachytherapy to treat locally advanced cervical cancer.
    Lee HJ; Kim YS; Shin SS; Nam JH; Kim YT; Han S; Choi EK
    Tumori; 2012; 98(5):615-21. PubMed ID: 23235757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.